Sunday, June 7, 2026
newmoneyfront.com
Advertisement
  • News
  • Share Market
  • Commodoties
  • Forex
  • Crypto
No Result
View All Result
  • News
  • Share Market
  • Commodoties
  • Forex
  • Crypto
No Result
View All Result
newmoneyfront.com
No Result
View All Result
Home Share Market

Jim Cramer’s top 10 things to watch in the stock market Wednesday

For your consideration by For your consideration
January 22, 2025
in Share Market
0
Jim Cramer’s top 10 things to watch in the stock market Wednesday
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

You might also like

Here are the 6 big things we’re watching in the stock market this week

SpaceX, Anthropic, and OpenAI IPOs could drag equity markets for years, warns Rob Arnott

Here are 3 forces that drove a whirlwind week for the stock market

US President Donald Trump displayed on a television during a news broadcast on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, Jan. 21, 2025. 

Michael Nagle | Bloomberg | Getty Images

My top 10 things to watch Wednesday, Jan. 22

1. Wall Street was tracking for a higher open on strong earnings after the S&P 500 and the Dow both rose Tuesday for the fifth straight session. The Nasdaq logged back-to-back gains. We looked how President Donald Trump‘s new initiatives will impact our Club portfolio stocks.

2. Netflix delivered monster quarterly beats on the top and bottom line, and the stock soared 15%. The streaming giant added a huge number of new customers, a record 19 million.

3. United Airlines reported blowout quarterly numbers, crushing estimates on earnings per share and revenue.  Pricing power was on display. Higher prices but better EPS.

4. GE Vernova pulled in huge orders. The company saw a big return to nuclear from existing stock. Trying to meet demand. Trying to hire. Strong on natural gas and electrification.

5. Club name Abbott Laboratories matched estimates on quarterly earnings and missed on revenue. Technically, full-year earnings per share guidance missed by a penny at the midpoint. I think management was being conservative with the outlook.

6. Dow stock Johnson & Johnson saw better than expected quarterly earnings on cancer drug growth. Huge numbers for Stelara for Crohn’s disease and Darzalex for multiple myeloma.

7. Procter & Gamble, also a Dow stock, beat on quarterly EPS and revenue with good organic sales growth. Excellent acceleration in growth. P&G also reiterated fiscal 2025 guidance.

8. Lead article in the medical journal Lancet: “Elevated blood pressure is the most important risk factor for cardiovascular disease.” Initial readouts show that GLP-1s can reduce blood pressure. Club name Eli Lilly and Novo Nordisk dominate in GLP-1s.

9. Morgan Stanley cut its Microsoft price target top to $540 per share from $548 but likes the set up ahead of next week’s earnings because of low expectations. I’ll let members know how I feel about the Club name at our Monthly Meeting at noon ET on Thursday.

10. It’s now Barclays’ turn to lower its price target on Club name Apple ahead of next week’s earnings. The analysts cut their PT by $1 per share to $183 and kept their sell-equivalent rating. I talked Tuesday about how we made so much money on Apple stock for the Club over the years.

Sign up for my Top 10 Morning Thoughts on the Market email newsletter for free

(See here for a full list of the stocks at Jim Cramer’s Charitable Trust.)

As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade.

THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY, TOGETHER WITH OUR DISCLAIMER.  NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.  NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.

Share30Tweet19
For your consideration

For your consideration

Recommended For You

Here are the 6 big things we’re watching in the stock market this week

by For your consideration
June 7, 2026
0
Here are the 6 big things we’re watching in the stock market this week

Subscribe to CNBC PROSubscribe to Investing ClubLicensing & ReprintsCNBC CouncilsSelect Personal FinanceJoin the CNBC PanelClosed CaptioningDigital ProductsNews ReleasesInternshipsCorrectionsAbout CNBCSite MapPodcastsCareersHelpContactNews TipsGot a confidential news tip? We want to...

Read moreDetails

SpaceX, Anthropic, and OpenAI IPOs could drag equity markets for years, warns Rob Arnott

by For your consideration
June 7, 2026
0
SpaceX, Anthropic, and OpenAI IPOs could drag equity markets for years, warns Rob Arnott

Rob Arnott has a message for anyone who thinks the coming wave of tech mega-IPOs is unambiguously great news for markets: think again. The founder and chairman of...

Read moreDetails

Here are 3 forces that drove a whirlwind week for the stock market

by For your consideration
June 6, 2026
0
Here are 3 forces that drove a whirlwind week for the stock market

Subscribe to CNBC PROSubscribe to Investing ClubLicensing & ReprintsCNBC CouncilsSelect Personal FinanceJoin the CNBC PanelClosed CaptioningDigital ProductsNews ReleasesInternshipsCorrectionsAbout CNBCSite MapPodcastsCareersHelpContactNews TipsGot a confidential news tip? We want to...

Read moreDetails

Crypto Exchanges Could Funnel $2 Trillion Into Stocks by 2031, Binance Research Says

by For your consideration
June 6, 2026
0
Crypto Exchanges Could Funnel $2 Trillion Into Stocks by 2031, Binance Research Says

Binance Research projects that crypto exchanges could channel $2 trillion in incremental capital and nearly 300 million new investors into global equity markets by 2031, positioning trading platforms...

Read moreDetails

Sensex Today | Stock Market LIVE Updates: Nifty may open around 23,450; Aurobindo Pharma in focus

by For your consideration
June 5, 2026
0
Sensex Today | Stock Market LIVE Updates: Nifty may open around 23,450; Aurobindo Pharma in focus

HomeMarket NewsSensex Today | Stock Market Highlights: Nifty slips below 23,400; Markets end lower for 2nd straight weekSensex Today | Stock Market Highlights: Markets ended slightly lower on...

Read moreDetails
Next Post
Travis Scott Donates “4X4” Merchandise Proceeds To LA Wildfires Response Fund

Travis Scott Donates "4X4" Merchandise Proceeds To LA Wildfires Response Fund

Related News

Spotify Confirms Switzerland Price Increases Ahead of Q3 Earnings Release — Individual Tops $20 Per Month, Family Approaches $34

Spotify Confirms Switzerland Price Increases Ahead of Q3 Earnings Release — Individual Tops $20 Per Month, Family Approaches $34

October 28, 2025
Bitcoin, Ethereum And XRP Rally As US-China Trade Breakthrough Lifts Global Markets

Bitcoin, Ethereum And XRP Rally As US-China Trade Breakthrough Lifts Global Markets

October 27, 2025
U.S. SEC Chair Says Working on ‘Innovation Exemption’ for DeFi Platforms

U.S. SEC Chair Says Working on ‘Innovation Exemption’ for DeFi Platforms

June 10, 2025

Browse by Category

  • Commodoties
  • Crypto
  • Finance News
  • Forex
  • Share Market
newmoneyfront.com

We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc. Check our landing page for details.

CATEGORIES

  • Commodoties
  • Crypto
  • Finance News
  • Forex
  • Share Market

BROWSE BY TAG

asx AUSTRALIA Bitcoin china christians Cryptocurrencies donald trump E-Commerce Economy Fed Tapering freedom INVESTMENT jpy Market Stories money Obligation peace profit russia shares stock market stocks Strategy Tax Trading truth

Copyright © 2024 newmoneyfront.com! Design by Freelancing Solution. All Rights Reserved.

No Result
View All Result
  • News
  • Share Market
  • Commodoties
  • Forex
  • Crypto

Copyright © 2024 newmoneyfront.com! Design by Freelancing Solution. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?